Company Info
Phone(415) 660-5320
Year Established
2009
Ticker
NRIX
Exchange
NASDAQ
Contacts
Arthur T. Sands, M.D., Ph.D.President & CEO
Christine Ring, Ph.D., J.D.
General Counsel
Gwenn Hansen, Ph.D.
CSO
Hans van Houte
CFO
Stefani A. Wolff
COO
Elizabeth Bosch, Ph.D.
VP, Alliance & Program Management
Company Description
Nurix Therapeutics, Formerly Kura Therapeutics, is a biopharmaceutical company focused on the discovery, development, and commercialization of small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders.
